Pfizer has claimed its first regulatory approval worldwide for Cibinqo, its JAK inhibitor for atopic dermatitis, from the UK's Medicines and Healthcare products Regulatory Agency (MHRA).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback